Related Experiment Video
Updated: May 30, 2025

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
Published on: April 3, 2017
Mechanisms of inflammatory microenvironment formation in cardiometabolic diseases: molecular and cellular
Menghua Liu1, Rumeng Chen1, Zhiwei Zheng1
1School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.
Insights
Inflammation drives cardiometabolic diseases like atherosclerosis, hypertension, and diabetic cardiomyopathy. Understanding these complex inflammatory pathways is key to developing targeted treatments for these conditions.
Area of Science:
- Cardiovascular Science
- Immunology
- Metabolic Disease Research
Background:
- Cardiometabolic diseases (CMD) are major global health burdens.
- Inflammation is a central mechanism in CMD pathogenesis.
- Atherosclerosis, hypertension, and diabetic cardiomyopathy share inflammatory underpinnings.
Purpose of the Study:
- To review the molecular and cellular inflammatory mechanisms in atherosclerosis, hypertension, and diabetic cardiomyopathy.
- To elucidate the role of the inflammatory microenvironment in these conditions.
- To highlight the complexity and diversity of inflammatory pathways in CMD.
Main Methods:
- Literature review focusing on molecular and cellular inflammatory processes.
- Analysis of key inflammatory mediators and pathways in specific CMDs.
- Synthesis of information on immune cell activation and signaling cascades.
Main Results:
- Atherosclerosis involves oxidized LDL, IL-6, and TNF-α, leading to foam cells and arterial thickening.
- Hypertension is linked to RAS activation, oxidative stress, endothelial dysfunction, and T-cell mediated inflammation.
- Diabetic cardiomyopathy features AGEs, RAGE activation, and inflammation damaging cardiac and microvascular function.
Conclusions:
- Inflammatory mechanisms in CMDs are intricate and varied.
- Deepening the understanding of these mechanisms is crucial.
- This knowledge will facilitate the development of personalized treatment strategies for CMDs.
Abstract:
Cardiometabolic diseases (CMD) are leading causes of death and disability worldwide, with complex pathophysiological mechanisms in which inflammation plays a crucial role. This review aims to elucidate the molecular and cellular mechanisms within the inflammatory microenvironment of atherosclerosis, hypertension and diabetic cardiomyopathy. In atherosclerosis, oxidized low-density lipoprotein (ox-LDL) and pro-inflammatory cytokines such as Interleukin-6 (IL-6) and Tumor Necrosis Factor-alpha (TNF-α) activate immune cells contributing to foam cell formation and arterial wall thickening. Hypertension involves the activation of the renin-angiotensin system (RAS) alongside oxidative stress-induced endothelial dysfunction and local inflammation mediated by T cells. In diabetic cardiomyopathy, a high-glucose environment leads to the accumulation of advanced glycation end products (AGEs), activating the Receptor for Advanced Glycation Endproducts (RAGE) and triggering inflammatory responses that further damage cardiac and microvascular function. In summary, the inflammatory mechanisms in different types of metabolic cardiovascular diseases are complex and diverse; understanding these mechanisms deeply will aid in developing more effective individualized treatment strategies.
Related Concept Videos
Inflammation
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Pathophysiology of Heart Failure
The Tumor Microenvironment
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation

